Monarch Partners Asset Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-406,652
Closed -$1.85M 165
2022
Q2
$1.85M Sell
406,652
-4,219
-1% -$20.8K 0.52% 98
2022
Q1
$2.21M Hold
410,871
0.49% 96
2021
Q4
$2.48M Buy
410,871
+34,772
+9% +$214K 0.5% 92
2021
Q3
$2.68M Buy
376,099
+228,522
+155% +$1.84M 0.39% 93
2021
Q2
$1.24M Buy
+147,577
New +$1.27M 0.18% 141

Other funds holding ULBI

Monarch Partners Asset Management's ULBI Position: Q3 2022 in Review

Monarch Partners Asset Management sold out of Ultralife (ULBI) in Q3 2022, closing a stake of 406,652 shares — an estimated $1.85M sold.

Monarch Partners Asset Management first reported a position in ULBI in Q2 2021 and held it in 5 quarters. The position peaked at $2.68M in Q3 2021. 30 funds tracked by Wall St. Rank hold ULBI as of Q3 2022.

  • Monarch Partners Asset Management reported no remaining Ultralife position as of Q3 2022 after selling out during the quarter.
  • Monarch Partners Asset Management sold 406,652 Ultralife shares in Q3 2022, an estimated $1.85M.
  • Monarch Partners Asset Management first reported a position in Ultralife in Q2 2021 and held it in 5 quarters.
  • Monarch Partners Asset Management's Ultralife position peaked at $2.68M in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Ultralife as of Q3 2022.

Based on Monarch Partners Asset Management's 13F filing for Q3 2022, filed 31 Oct 2022.